Objectives: Bipolar disorder has been studied from numerous angles, from pathological studies to large-scale genomic studies, overall making moderate gains toward an understanding of the disorder. With the advancement of induced pluripotent stem (iPS) cell technology, in vitro models based on patient samples are now available that inherently incorporate the complex genetic variants that largely are the basis for this disorder. A number of groups are starting to apply iPS technology to the study of bipolar disorder.
| BACKGROUND ON BIPOLAR DISORDER PATHOPHYSIOLOGY
Efforts to understand the etiology and pathology of bipolar disorder have ranged from genetic studies to post-mortem work, studies using neuroimaging, animal models, and now induced pluripotent stem (iPS) cells. It has long been known that a family history of bipolar disorder puts one at risk for developing the disorder. Family, twin, and adoption studies have all shown the disorder to be largely genetically heritable, with estimates from twin studies being as high 93%.
1 With the latest large-scale genome-wide association studies (GWASs), 25%-30% of the heritability has been captured. 2 (In these studies, the results are finding particular variations of common single nucleotide polymorphisms [SNPs] that are present in individuals with bipolar disorder at a greater frequency than in controls. While these variations of the SNPs are likely not causative genetic changes, they are likely linked to some nearby unknown genetic change that presumably is causative.)
With these studies, common genetic variants with allele frequencies ≥5% can be examined. Detecting more rare variants will likely require whole-genome sequencing. Other approaches to understanding the illness, such as post-mortem and imaging studies, have produced varied results of unclear significance, making it difficult to draw larger conclusions. Most animal models of either depressive-like or manialike behavior are based on over-or underexpression of specific genes in mice, failing to capture the genetic complexity, the spontaneous cyclical nature of the episodes, or the specific behaviors of individuals with bipolar disorder. One example from the interesting findings so far revolves around voltage gated calcium channels. These channels have been associated with bipolar disorder but also schizophrenia in GWAS experiments. More recent work with iPS cells has also shown that, at least in some experimental paradigms, bipolar iPS neurons have hyperactive calcium signaling events that even normalize with lithium, but only in cells from patients that also respond to lithium. 3 Overall, the data support a heritable complex genetic disorder, with hundreds of genes contributing to and being the predominant cause of bipolar disorder. While it has been challenging making progress toward an understanding of bipolar disorder, experimental tools are becoming more powerful and comprehensive.
While the genetic studies have been incredibly informative and pointed further experiments in the direction of certain signaling pathways and ion channels, it has proved difficult to know how to experimentally model a complex set of genetic risk alleles. Furthermore, In summary, there are now multiple cell sources for deriving iPS and other alternative cell types that can be used to study neural cells in vitro. They vary in how precisely they represent the cell type of interest. Some retain more markers of the source tissue, and they can also vary in their differentiation potential. Keeping in mind the cellular source and how they were reprogrammed is an important experimental factor to keep in mind when planning and evaluating experiments.
| BACKGROUND ON IPS CELLS

| CELLULAR SOURCES OF IPS CELLS AND RELATED ALTERNATIVES
| STUDIES OF BIPOLAR DISORDER
Below we will provide a review of the studies published so far using iPS cells to gain further insight into bipolar disorder. The studies reviewed have been grouped by the themes of the findings so far, with the relevant underlying data from each paper being discussed.
When a paper is first introduced, a general overview of that paper is given. Here, it is worth providing a general overview of the differences between the papers (see Table 2 ). In general, there is a significant amount of variation in the differentiation protocols, with some studies making more differentiated neurons, such as forebrain or dentate gyrus granule cells. Additionally, some studies looked at early neurons, just 2 weeks old, whereas others allowed them to mature until 12 weeks. Wang et al were able to directly induce neurons from fibroblasts, 10 saving a significant amount of time in the challenging process of reprogramming fibroblasts, but this may not have been as accurate a model. Additionally, the sample numbers generally tended to be low, at most 12 cases versus six controls.
Another important difference is sample selection; as bipolar disorder is largely a complex genetic disorder, some efforts were made to focus on a clinical phenotype (such as using lithium-responsive samples) or on individuals with similar genetic profiles (such as studying bipolar disorder within a family or larger pedigree), both strategies worth considering to improve the chance of making meaningful discoveries. Another potentially important difference is the age of the iPS neurons. In many ways they are likely to appear young, like an early embryonic neuron, but they may also reflect the age of the patient, such as having telomere shortening. Some studies looked at these neurons months after differentiation to examine more mature synaptic development. In general, many of the iPS neurons from 
| USING BIPOLAR IPS CELLS FOR DRUG SCREENING APPLICATIONS
A cellular model of bipolar disorder would allow for high-throughput screening and drug discovery. Cellular models allow for rapid screen- Work by Madison et al also suggests that cellular proliferation may be altered in bipolar disorder. 16 They explored bipolar iPS cells using a novel experimental paradigm. As bipolar disorder is a complex genetic disorder with quite possibly different complex genetic forms of the disorder, they attempted to eliminate this variable by studying bipolar disorder within a family, choosing two affected siblings and their unaffected parents as the subjects. However, as bipolar disorder is highly heritable, with a heritability of at least 80%, and individuals usually have a family history of mood disorder, this raises the difficult question of whether the unaffected parents did not have the critical genetic insults, thus being able to serve as appropriate controls, or had they somehow only avoided the environmental insult, thus having quite a similar genetic risk for bipolar disorder and making poor genetic controls? As it was likely to shed some light on this, wholegenome SNP profiling was performed. In terms of risk alleles for bipolar disorder, one interesting association was reported. The mother was heterozygous for a CACNA1C (calcium voltage-gated channel subunit alpha1 C) risk allele. CNVs (copy number variants) were also analyzed and no large (<10 kb) de novo CNVs were uniquely found in both affected siblings. In terms of understanding differentiation potential, the iPS cells were exposed to factors leading to a general neural differenti- 
| CHANGES IN ELECTRICAL ACTIVITY
More and more data are pointing toward aberrant calcium signaling in bipolar neurons. Calcium abnormalities were first reported in platelets by Dubovsky et al 17 GWAS results have also highlighted numerous L-type calcium channel subunits, strongly suggesting that calcium is dysregulated in some manner in bipolar disorder. iPS neurons provide an excellent way to study calcium signaling and carefully investigate the electrical properties of specific neuron types in bipolar disorder.
In the study by Chen et al, where they generated forebrain neurons, they allowed the neurons to mature in culture for 12 weeks. 15 At this point, they measured calcium transients and wave amplitude, noting that they were decreased in bipolar neurons pre-treated with lithium.
In Madison et al's work, they also characterized RNA expression in the 6-week-old neurons (central neural progenitor cells; TuJ1 and MAP2 positive). 16 Interestingly, five of the differentially expressed genes were related to calcium channels, some with increased and some with decreased expression.
Recently, Mertens et al studied 3-week-old dentate granule-like neurons (produced from iPS cells), from three lithium-responsive bipolar individuals, three non-responsive bipolar individuals, and four controls. 3 After transcriptome studies suggested aberrant electrical properties in the cases, they performed patch clamp experiments, noticing a general theme of hyperexcitability. Specifically, there was increased sodium channel activation in neurons from bipolar individuals. Additionally, action potentials were altered, with lower thresholds, increased numbers of evoked potentials, increased maximal amplitudes, and higher spontaneous frequencies. When they looked at network activity through monitoring a fluorescent calcium indicator, they similarly saw increased calcium events. Most interestingly, they saw these in both the lithium-responsive and non-responsive neurons.
However, when treated with lithium for 1 week, some aspects of the hyperexcitability as well as the calcium events were reduced only in the neurons from lithium-responsive patients. Also, when these neurons were allowed to mature more, the hyperexcitability reversed.
| MITOCHONDRIAL DEFECTS
Mitochondrial dysfunction also may play a role in bipolar etiology.
Quiroz et al discussed the range of evidence suggesting how mitochondrial problems may interface with calcium signaling, handling oxidative stress, and even synaptic plasticity. 18 In this context, Mertens et al investigated mitochondrial function, studying mitochondrial membrane potential. 3 They noticed "enhanced mitochondrial function." Additionally, the size of the mitochondria was reduced. This reduced size has been associated with increased mitochondrial transport, possibly helping induce the increased neuronal activity discussed above. Supporting this hypothesis, lithium treatment rescued the mitochondrial size phenotype only in the lithium-responsive samples.
| GENE EXPRESSION
Many of the studies reviewed above also thoroughly examined RNA expression through microarrays or RNA-sequencing (RNA-seq) studies. Each of the studies used different cell types, with a different experimental paradigm, and unique differentiation protocols. Nevertheless, it is useful to consider the general findings from RNA studies. Madison et al used both nanostring sequencing and RNA-seq, finding some genes differentially expressed, such as PAX6 (paired box 6) (playing a role in neurogenesis) and CACNA1C and FGF14 (fibroblast growth factor 14) (with roles in regulating sodium and calcium channel function). 16 Mertens et al also used RNA-seq to characterize the dentate granule-like neurons, finding genes related to increased mitochondrial function, calcium signaling, ligand-receptor function, and protein kinase A and C (PKA, PKC) function, and genes important for action potentials. 3 They posited that increased mitochondrial function as well as increased PKA/PKC activity may be related to the increased action potentials seen.
Bavamian et al specifically investigated expression levels of microRNA-34a (miR-34a), a microRNA that is thought to play a role in neural development and whose levels are affected by the mood stabilizers lithium and valproic acid. 19 They first investigated this in postmortem cerebellum samples, and noticed increased levels of miR-34a in bipolar samples. They wanted to eliminate potential biases from working with post-mortem tissues, so they also investigated this in both iPS-neural progenitors and differentiated neurons. They worked with just one bipolar sample and one control sample, but did see a consistent trend of higher miR-34a levels in the bipolar individual. To expand their sample numbers, they also examined this in induced neurons, made from fibroblasts, and found the same effect, supporting both their finding and the use of induced neurons. They then identified putative miR-34a targets that overlap with genes from the bipolar GWAS studies. Through a variety of expression correlation studies, using miR-34a overexpression and anti-miR-34a expression, and studies of neuron morphology, they obtained data supporting miR-34a differential upregulation in bipolar disorder, resulting in decreases in the amounts of ANK3 and CACNB3 (ankyrin 3, calcium voltage-gated channel auxiliary subunit beta 3) , which are also associated with limited neuronal differentiation.
Another recent study focused on microarray expression data from iPS neurons from an Old Order Amish pedigree. 20 They compared four affected sibs and cousins with four controls, comparing cells at the neural progenitor stage, 2-week-old "early" neurons, and 4-week-old "late" neurons. The expression data when examined through PCA for similarity found that the bipolar and control samples were not different on a global scale, but that the samples still separated based on the stages above. They did find differentially expressed genes between bipolar individuals and controls at the late stage. When the groups were compared based on gene networks, such as gene ontology analysis, they found differences in metabolic processes, protein transport, the WNT pathway, and GSK3beta, glycogen synthase kinase 3 beta.
| CONCLUSION
The early work using iPS cells to study bipolar disorder has shown some promising findings. Additionally, iPS neurons are an important part of changing how we care for patients with bipolar disorder. One day, could we, similarly to our colleagues in oncology, run a series of lab tests that show us the particular genetic form of bipolar disorder we are treating? We also look forward to the day when we can similarly provide a prognosis, giving the patient a sense of their risk for manic episodes, and being able to recommend optimal treatments for that individual patient based on pharmacogenetics. We already believe that bipolar disorder is really a collection of different disorder subtypes driven by different genetic pathologies affecting specific cellular systems and ultimately the brain in specific ways. For example, there is a subset of patients, approximately 25%, who respond well to lithium. Being able to share with the patient a better understanding of their subtype of bipolar disorder and what specific treatments will work for them is a dream, but it is now a realistic dream. Ultimately, we believe that studying bipolar disorder with iPS cells will be one of the key tools that will help us understand the relationship between the complex genetics of bipolar disorder, the cellular pathology and change at the level of brain circuitry, and ultimately provide more effective treatment for individuals with bipolar disorder.
